Skip to main content
. Author manuscript; available in PMC: 2017 Dec 9.
Published in final edited form as: Clin Cancer Res. 2011 Oct 5;17(22):7183–7193. doi: 10.1158/1078-0432.CCR-11-0981

Table 5.

Gene Expression Level Change and Treatment Response

Response Group Change in CTC Levels from Baseline to Week 8
Mean Median Range Quartiles p-value

CK19
 Yes (N=21) − 350 0 −4063 - 865 25%: −1
75%: −204
0.25
 No (N=38) −75 −2 −16,272-11,906 25%: 2
75%: −13

Mammoglobin
 Yes (N=21) − 67 0 −738 - 36.0 25%: 0
75%: −11
0.05
 No (N=38) − 32 0 −970 - 313 25%: 7
75%: − 0.1

Response Group Change in CTC Levels from Baseline to End of Treatment
Mean Median Range Quartiles p-value

CK19
 Yes (N=13) 2732 0 −3392 - 39,385 25%: 2
75% −141
0.34
 No (N=31) − 479 0 −15,332 - 999 25%: 10
75%: − 8

Mammoglobin
 Yes (N=13) 1176 0 −192 -15,506 25%: 0
75%: −0.6
0.09
 No (N=31) −0.06 0 −970 -1459 25%: 9
75% −0.1